Education and treatment adherence during the COVID-19 pandemic. Response to: 'Adherence to medication in patients with rheumatic diseases during COVID-19 pandemic' by Khabbazi et al

Ann Rheum Dis. 2022 Oct;81(10):e201. doi: 10.1136/annrheumdis-2020-218791. Epub 2020 Sep 7.
No abstract available

Keywords: antirheumatic agents; autoimmune diseases; therapeutics.

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19*
  • Humans
  • Medication Adherence
  • Pandemics
  • Rheumatic Diseases* / drug therapy
  • Treatment Adherence and Compliance